title: A case of quetiapine XR and divalproex-associated neutropenia followed by successful use of ziprasidone.
authors.forename: Kristi R
authors.initials: KR
authors.lastname: Estabrook
authors.forename: Mara
authors.initials: M
authors.lastname: Pheister
mesh_terms: D000328:Adult; D014151:Anti-Anxiety Agents / Q000009:adverse effects / Q000627:therapeutic use; D018692:Antimanic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D001714:Bipolar Disorder / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D002998:Clonazepam / Q000009:adverse effects / Q000627:therapeutic use; D003692:Delayed-Action Preparations; D003702:Delusions / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D003987:Dibenzothiazepines / Q000009:adverse effects* / Q000627:therapeutic use; D016903:Drug Monitoring; D004359:Drug Therapy, Combination / Q000009:adverse effects; D006801:Humans; D008297:Male; D008803:Mianserin / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D000078785:Mirtazapine; D009503:Neutropenia / Q000139:chemically induced*; D019338:Polypharmacy; D000069348:Quetiapine Fumarate; D059020:Suicidal Ideation; D016896:Treatment Outcome; D014635:Valproic Acid / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D014151:Anti-Anxiety Agents; D018692:Antimanic Agents; D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D003987:Dibenzothiazepines; D008803:Mianserin; D000069348:Quetiapine Fumarate; D002998:Clonazepam; D014635:Valproic Acid; D000078785:Mirtazapine